CING Stock Summary and Trading Ideas (Cingulate | NASDAQ:CING)

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

What symbol and exchange does Cingulate shares trade?

Cingulate trades on the NASDAQ stock market under the symbol CING.

What is Cingulate stock price doing today?

As of April 7, 2026, CING stock price declined to $5.99 with 73,843 million shares trading.

What is Cingulate's Beta?

CING has a beta of 0.58, meaning it tends to be less sensitive to market movements. CING has a correlation of 0.02 to the broad based SPY ETF.

How much is Cingulate worth?

CING has a market cap of $69.66 million. This is considered a Micro Cap stock.

What is the highest and lowest price Cingulate traded in the last 3 year period?

In the last 3 years, CING traded as high as $285.58 and as low as $1.80.

What are the top ETFs holding Cingulate?

The top ETF exchange traded funds that CING belongs to (by Net Assets): VTI, VXF.

Is Cingulate (CING) a good investment?

CING has outperformed the market in the last year with a return of +58.5%, while the SPY ETF gained +30.6%. In the last 3 month period, CING beat the market returning +28.0%, while SPY returned -5.4%. However, in the most recent 2 weeks CING has underperformed the stock market by returning -13.6%, while SPY returned -0.4%.

What are the support and resistance levels for Cingulate (CING)?

CING support price is $5.74 and resistance is $6.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CING shares will trade within this expected range on the day.